Company
Headquarters: Sun Valley, CA, United States
CEO: Mr. Paul D. Lisenby
$656,195
USD as of Jan. 1, 2024
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Multicorp International, Inc. does not have significant operations. It focuses on identifying and acquiring companies that are operating in medical and technical sectors. It was formerly known as XTend Medical Corporation and changed its name to MultiCorp International, Inc. in August 2012. The company is based in Agoura Hills, California.
Top 1-year algo backtest: +284.14%
$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Multicorp International, Inc. has the following listings and related stock indices.
Stock: OTC: MCIC wb_incandescent